• Skip to main content
  • Accessibility information

Site navigation

  • Study
  • Research
  • About us
  • Student life
  • Alumni
  • Support us
  • Contact

Site tools

A-Z Lists
  • Subjects A-Z
  • Staff A-Z
  • Academic units A-Z
University of Glasgow logo
  • Home
  • Enlighten
  • Publications

Enlighten Publications

  • About
  • Latest Additions
  • Search
  • Browse
    • Browse by Author
    • Browse by Year
    • Browse by Journal
    • Browse by Research Funder Name
    • Browse by Colleges/Schools
  • Open Access
  • ORCID
  • My Publications
    • Login

In this section

    Browse by Research Project Code

    Up a level
    Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0

    Parry, N., Busch, C., Aßmann, V., Cassels, J., Hair, A., Helgason, G. V. , Wheadon, H. and Copland, M. (2022) BH3 mimetics in combination with nilotinib or ponatinib represent a promising therapeutic strategy in blast phase chronic myeloid leukemia. Cell Death Discovery, 8, 457. (doi: 10.1038/s41420-022-01211-1) (PMID:36379918) (PMCID:PMC9666353)

    Ibrahim, A., Bilsland, A. , Rickelt, S., Morris, J. and Stein, T. (2021) A matrisome RNA signature from early-pregnancy mouse mammary fibroblasts predicts distant metastasis-free breast cancer survival in humans. Breast Cancer Research, 23, 90. (doi: 10.1186/s13058-021-01470-3) (PMID:34565423) (PMCID:PMC8474794)

    Chantkran, W., Hsieh, Y.-C., Zheleva, D., Frame, S., Wheadon, H. and Copland, M. (2021) Interrogation of novel CDK2/9 inhibitor fadraciclib (CYC065) as a potential therapeutic approach for AML. Cell Death Discovery, 7, 137. (doi: 10.1038/s41420-021-00496-y) (PMID:34112754) (PMCID:PMC8192769)

    This list was generated on Wed Mar 29 01:36:24 2023 BST.

    Back to top

    Enlighten

    • Contact us
    • Privacy Notice

    The University of Glasgow is a registered Scottish charity: Registration Number SC004401